Clinical Trial: The Era of Targeted Immunotherapy: Timing of Radiotherapy and Interventional Therapy in Patients with Primary Liver Cancer and Portal Vein Cancer Thrombus: A Prospective Cohort Study (China)

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Era of Targeted Immunotherapy: Timing of Radiotherapy and Interventional Therapy in Patients with Primary Liver Cancer and Portal Vein Cancer Thrombus: A Prospective Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131897

Registration Time: 2026/09/07

Type: Observational study

Primary Sponsor: The First Hospital of Jilin University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=308876

Published by HT Digital Content Services with permission from Health Daily Digest....